Site-specific disulfide capture of agonist and antagonist peptides on the C5a receptor

被引:27
作者
Buck, E
Bourne, H
Wells, JA [1 ]
机构
[1] Sunesis Pharmaceut Inc, San Francisco, CA 94080 USA
[2] Univ Calif San Francisco, Dept Mol Pharmacol, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.C400500200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The manner by which peptidic ligands bind and activate their corresponding G-protein-coupled receptors is not well understood. One of the better characterized peptidic ligands is the chemotactic cytokine complement factor 5a (C5a), a 74-amino acid helical bundle. Previous studies showed 6-mer peptide analogs derived from the C terminus of the C5a ligand can bind to C5aR (K-d values similar to0.1-1 muM) and either agonize or antagonize the receptor (Gerber, B. O., Meng, E. C., Dotsch, V., Baranski, T. J., and Bourne, H. R. (2001) J. Biol. Chem. 276, 3394-3400). Here, we provide direct biochemical data using disulfide trapping to support a model that these peptides bind within a transmembrane helical triad formed by a-helices III, VI, and VII. We show that the three amino acids on the C terminus of the peptide analogs bind too weakly to exert a functional effect themselves. However, when a cysteine residue is placed on their N terminus they can be trapped by disulfide interchange to specific cysteines in helix III and VI and not to other cysteines, engineered into the C5aR. The trapped peptides function as agonists or partial antagonists, similar to the non-covalent parents from which they were derived. These data help to further refine the binding mode for C5a to the C5aR and suggest an approach and a binding site that may be applicable to studying other peptide binding receptors.
引用
收藏
页码:4009 / 4012
页数:4
相关论文
共 33 条
[1]   C5a receptor activation - Genetic identification of critical residues in four transmembrane helices [J].
Baranski, TJ ;
Herzmark, P ;
Lichtarge, O ;
Gerber, BO ;
Trueheart, J ;
Meng, EC ;
Iiri, T ;
Sheikh, SP ;
Bourne, HR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (22) :15757-15765
[2]   Molecular tinkering of G protein-coupled receptors: an evolutionary success [J].
Bockaert, J ;
Pin, JP .
EMBO JOURNAL, 1999, 18 (07) :1723-1729
[3]   SITE-SPECIFIC MUTAGENESIS OF RESIDUES IN THE HUMAN C5A ANAPHYLATOXIN WHICH ARE INVOLVED IN POSSIBLE INTERACTION WITH THE C5A RECEPTOR [J].
BUBECK, P ;
GROTZINGER, J ;
WINKLER, M ;
KOHL, J ;
WOLLMER, A ;
KLOS, A ;
BAUTSCH, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 219 (03) :897-904
[4]   Mapping the ligand-binding site on the C5a receptor:: Arginine74 of C5a contacts aspartate282 of the C5a receptor [J].
Cain, SA ;
Coughlan, T ;
Monk, PN .
BIOCHEMISTRY, 2001, 40 (46) :14047-14052
[5]   Residues 21-30 within the extracellular N-terminal region of the C5a receptor represent a binding domain for the C5a anaphylatoxin [J].
Chen, ZG ;
Zhang, XL ;
Gonnella, NC ;
Pellas, TC ;
Boyar, WC ;
Ni, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10411-10419
[6]   ARGININE-206 OF THE C5A RECEPTOR IS CRITICAL FOR LIGAND RECOGNITION AND RECEPTOR ACTIVATION BY C-TERMINAL HEXAPEPTIDE ANALOGS [J].
DEMARTINO, JA ;
KONTEATIS, ZD ;
SICILIANO, SJ ;
VANRIPER, G ;
UNDERWOOD, DJ ;
FISCHER, PA ;
SPRINGER, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (27) :15966-15969
[7]  
DEMARTINO JA, 1994, J BIOL CHEM, V269, P14446
[8]   Conversion of agonist site to metal-ion chelator site in the β2-adrenergic receptor [J].
Elling, CE ;
Thirstrup, K ;
Holst, B ;
Schwartz, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12322-12327
[9]   Tethering: Fragment-based drug discovery [J].
Erlanson, DA ;
Wells, JA ;
Braisted, AC .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2004, 33 :199-223
[10]   Site-directed ligand discovery [J].
Erlanson, DA ;
Braisted, AC ;
Raphael, DR ;
Randal, M ;
Stroud, RM ;
Gordon, EM ;
Wells, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (17) :9367-9372